Jin Xing Qi
Chairman en HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD .
Fortuna: 1 642 M $ al 31/03/2024
Perfil
Jin Xing Qi fundó Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Ltd. Actualmente, es presidente de Hangzhou Binjiang Real Estate Group Co. y presidente de Hangzhou Pute Equity Investment Co. Ltd. El Sr. Qi también forma parte del consejo de Hangzhou Binjiang Investment Holding Co., Ltd. y de Hangzhou Xincheng Time Square Real Estate Co., Ltd. y es vicepresidente de Zhejiang Management Research. En el pasado, el Sr. Qi ocupó el cargo de director de Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Jin Xing Qi obtuvo un MBA en la Universidad de Zhejiang.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2023 | 1 505 912 522 ( 55.93% ) | 1 386 M $ | 31/03/2024 | |
| 30/09/2023 | 278 698 950 ( 64.95% ) | 256 M $ | 31/03/2024 |
Cargos activos de Jin Xing Qi
| Empresas | Cargo | Inicio |
|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Chairman | 01/01/2003 |
| Zhejiang Management Research | Corporate Officer/Principal | 24/02/2010 |
| Hangzhou Pute Equity Investment Co. Ltd. | Chairman | 07/04/2011 |
Hangzhou Binjiang Investment Holding Co., Ltd.
 Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding private company based in Hangzhou, China. | Director/Board Member | - |
Hangzhou Xincheng Time Square Real Estate Co., Ltd.
 Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The private company is based in Hangzhou, China. | Director/Board Member | - |
Antiguos cargos conocidos de Jin Xing Qi.
| Empresas | Cargo | Fin |
|---|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Founder | - |
Formación de Jin Xing Qi.
| Zhejiang University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| Empresas privadas | 5 |
|---|---|
Hangzhou Binjiang Investment Holding Co., Ltd.
Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding private company based in Hangzhou, China. | Miscellaneous |
| Zhejiang Management Research | |
Hangzhou Xincheng Time Square Real Estate Co., Ltd.
Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The private company is based in Hangzhou, China. | Finance |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Hangzhou Pute Equity Investment Co. Ltd. | Finance |
- Bolsa de valores
- Insiders
- Jin Xing Qi
